These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12440382)

  • 1. T cell-based therapeutic vaccination for spinal cord injury.
    Schwartz M; Hauben E
    Prog Brain Res; 2002; 137():401-6. PubMed ID: 12440382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.
    Hauben E; Butovsky O; Nevo U; Yoles E; Moalem G; Agranov E; Mor F; Leibowitz-Amit R; Pevsner E; Akselrod S; Neeman M; Cohen IR; Schwartz M
    J Neurosci; 2000 Sep; 20(17):6421-30. PubMed ID: 10964948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens.
    Hauben E; Ibarra A; Mizrahi T; Barouch R; Agranov E; Schwartz M
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15173-8. PubMed ID: 11752461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease.
    Hauben E; Agranov E; Gothilf A; Nevo U; Cohen A; Smirnov I; Steinman L; Schwartz M
    J Clin Invest; 2001 Aug; 108(4):591-9. PubMed ID: 11518733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury.
    Hauben E; Gothilf A; Cohen A; Butovsky O; Nevo U; Smirnov I; Yoles E; Akselrod S; Schwartz M
    J Neurosci; 2003 Sep; 23(25):8808-19. PubMed ID: 14507981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective autoimmunity is a physiological response to CNS trauma.
    Yoles E; Hauben E; Palgi O; Agranov E; Gothilf A; Cohen A; Kuchroo V; Cohen IR; Weiner H; Schwartz M
    J Neurosci; 2001 Jun; 21(11):3740-8. PubMed ID: 11356861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of autoimmunity on recovery of function in adult rats following spinal cord injury.
    Lü HZ; Xu L; Zou J; Wang YX; Ma ZW; Xu XM; Lu PH
    Brain Behav Immun; 2008 Nov; 22(8):1217-30. PubMed ID: 18625299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries.
    Schwartz M; Kipnis J
    Trends Mol Med; 2001 Jun; 7(6):252-8. PubMed ID: 11378514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term production of BDNF and NT-3 induced by A91-immunization after spinal cord injury.
    Martiñón S; García-Vences E; Toscano-Tejeida D; Flores-Romero A; Rodriguez-Barrera R; Ferrusquia M; Hernández-Muñoz RE; Ibarra A
    BMC Neurosci; 2016 Jun; 17(1):42. PubMed ID: 27364353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.
    Kipnis J; Mizrahi T; Hauben E; Shaked I; Shevach E; Schwartz M
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15620-5. PubMed ID: 12429857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy.
    Jones TB; Basso DM; Sodhi A; Pan JZ; Hart RP; MacCallum RC; Lee S; Whitacre CC; Popovich PG
    J Neurosci; 2002 Apr; 22(7):2690-700. PubMed ID: 11923434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response.
    Kipnis J; Yoles E; Schori H; Hauben E; Shaked I; Schwartz M
    J Neurosci; 2001 Jul; 21(13):4564-71. PubMed ID: 11425884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive immunization with myelin basic protein activated T cells suppresses axonal dieback but does not promote axonal regeneration following spinal cord hemisection in adult rats.
    Wang HJ; Hu JG; Shen L; Wang R; Wang QY; Zhang C; Xi J; Zhou JS; Lü HZ
    Int J Neurosci; 2012 Aug; 122(8):458-65. PubMed ID: 22463720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sell Memorial Lecture. Helping the body to cure itself: immune modulation by therapeutic vaccination for spinal cord injury.
    Schwartz M
    J Spinal Cord Med; 2003; 26 Suppl 1():S6-10. PubMed ID: 12696569
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury.
    Hauben E; Nevo U; Yoles E; Moalem G; Agranov E; Mor F; Akselrod S; Neeman M; Cohen IR; Schwartz M
    Lancet; 2000 Jan; 355(9200):286-7. PubMed ID: 10675079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic neuroprotection with A91 improves the outcome of spinal cord injured rats.
    Ibarra A; Sosa M; García E; Flores A; Cruz Y; Mestre H; Martiñón S; Pineda-Rodríguez BA; Gutiérrez-Ospina G
    Neurosci Lett; 2013 Oct; 554():59-63. PubMed ID: 24012811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury.
    Perera CJ; Duffy SS; Lees JG; Kim CF; Cameron B; Apostolopoulos V; Moalem-Taylor G
    J Neuroinflammation; 2015 Feb; 12():28. PubMed ID: 25885812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats.
    Jones TB; Ankeny DP; Guan Z; McGaughy V; Fisher LC; Basso DM; Popovich PG
    J Neurosci; 2004 Apr; 24(15):3752-61. PubMed ID: 15084655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of protective autoimmunity by immunization with a neural-derived peptide is ineffective in severe spinal cord injury.
    Martiñón S; García E; Gutierrez-Ospina G; Mestre H; Ibarra A
    PLoS One; 2012; 7(2):e32027. PubMed ID: 22348141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
    Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Zeng L; Long ZY; Wu YM
    Biomaterials; 2011 Nov; 32(31):7988-98. PubMed ID: 21784510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.